Week in review: Orphan status, Demodex drug, embedded eyelash

This week, the FDA awards orphan drug designation to a nonviral gene therapy for retinitis pigmentosa, a novel eye drop for Demodex blepharitis shines in phase 2 trials and an eyelash embedded in the retina causes ocular inflammation.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553